Literature DB >> 12920505

Low-affinity interactions of BODIPY-FL-GTPgammaS and BODIPY-FL-GppNHp with G(i)- and G(s)-proteins.

Andreas Gille1, Roland Seifert.   

Abstract

BODIPY-FL-guanosine 5'-[gamma-thio]triphosphate (B-GTPgammaS) and BODIPY-FL-guanosine 5'-[beta,gamma-imido]triphosphate (B-GppNHp) induce fluorescence changes upon binding to purified G(s)/G(i)-proteins and were suggested to serve as probes for monitoring receptor-mediated G-protein activation. However, B-GTPgammaS and B-GppNHp bound to receptor-Galpha(s)/Galpha(i) fusion proteins expressed in Sf9 cell membranes with 1100- to 5600-fold- and 17- to 55-fold lower affinity than GTPgammaS and GppNHp, respectively. The affinity of B-GTPgammaS/B-GppNHp for G(s)/G(i)-proteins was considerably lower than the affinity of N-methylanthraniloyl (MANT)-substituted GTP analogs for G(s)/G(i)-proteins. B-GTPgammaS/B-GppNHp were much less potent than GTPgammaS/GppNHp at regulating adenylyl cyclase (AC) via G(s)- and G(i)-proteins. B-GTPgammaS/B-GppNHp were similarly efficient as GTPgammaS/GppNHp at activating G(i), but less efficient at activating G(s). In contrast to MANT-GTPgammaS/MANT-GppNHp, B-GTPgammaS/B-GppNHp were inefficient at directly inhibiting AC. In conclusion, the bulky BODIPY group strongly reduces the affinity of GTPgammaS/GppNHp for G-proteins, limiting the use of B-GTPgammaS/B-GppNHp as fluorescence probes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12920505     DOI: 10.1007/s00210-003-0783-7

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  22 in total

1.  Fluorescent BODIPY-GTP analogs: real-time measurement of nucleotide binding to G proteins.

Authors:  D P McEwen; K R Gee; H C Kang; R R Neubig
Journal:  Anal Biochem       Date:  2001-04-01       Impact factor: 3.365

2.  Distinct guanine nucleotide binding and release properties of the three Gi proteins.

Authors:  D J Carty; E Padrell; J Codina; L Birnbaumer; J D Hildebrandt; R Iyengar
Journal:  J Biol Chem       Date:  1990-04-15       Impact factor: 5.157

3.  Purification and characterization of Go alpha and three types of Gi alpha after expression in Escherichia coli.

Authors:  M E Linder; D A Ewald; R J Miller; A G Gilman
Journal:  J Biol Chem       Date:  1990-05-15       Impact factor: 5.157

Review 4.  Fluorescent nucleotide analogs: synthesis and applications.

Authors:  D M Jameson; J F Eccleston
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

5.  The olfactory G protein G(alphaolf) possesses a lower GDP-affinity and deactivates more rapidly than G(salphashort): consequences for receptor-coupling and adenylyl cyclase activation.

Authors:  H Y Liu; K Wenzel-Seifert; R Seifert
Journal:  J Neurochem       Date:  2001-07       Impact factor: 5.372

Review 6.  G protein mechanisms: insights from structural analysis.

Authors:  S R Sprang
Journal:  Annu Rev Biochem       Date:  1997       Impact factor: 23.643

7.  Effects of guanine, inosine, and xanthine nucleotides on beta(2)-adrenergic receptor/G(s) interactions: evidence for multiple receptor conformations.

Authors:  R Seifert; U Gether; K Wenzel-Seifert; B K Kobilka
Journal:  Mol Pharmacol       Date:  1999-08       Impact factor: 4.436

8.  Expression of Gs alpha in Escherichia coli. Purification and properties of two forms of the protein.

Authors:  M P Graziano; M Freissmuth; A G Gilman
Journal:  J Biol Chem       Date:  1989-01-05       Impact factor: 5.157

9.  2'(3')-O-(N-methylanthraniloyl)-substituted GTP analogs: a novel class of potent competitive adenylyl cyclase inhibitors.

Authors:  Andreas Gille; Roland Seifert
Journal:  J Biol Chem       Date:  2003-02-03       Impact factor: 5.157

10.  Guanine nucleotide inhibition of cyc- S49 mouse lymphoma cell membrane adenylyl cyclase.

Authors:  J D Hildebrandt; J Hanoune; L Birnbaumer
Journal:  J Biol Chem       Date:  1982-12-25       Impact factor: 5.157

View more
  5 in total

Review 1.  Targeting opioid receptor heterodimers: strategies for screening and drug development.

Authors:  Achla Gupta; Fabien M Décaillot; Lakshmi A Devi
Journal:  AAPS J       Date:  2006-03-10       Impact factor: 4.009

2.  Differential inhibition of various adenylyl cyclase isoforms and soluble guanylyl cyclase by 2',3'-O-(2,4,6-trinitrophenyl)-substituted nucleoside 5'-triphosphates.

Authors:  Srividya Suryanarayana; Martin Göttle; Melanie Hübner; Andreas Gille; Tung-Chung Mou; Stephen R Sprang; Mark Richter; Roland Seifert
Journal:  J Pharmacol Exp Ther       Date:  2009-06-03       Impact factor: 4.030

3.  Integration of Fourier Transform Infrared Spectroscopy, Fluorescence Spectroscopy, Steady-state Kinetics and Molecular Dynamics Simulations of Gαi1 Distinguishes between the GTP Hydrolysis and GDP Release Mechanism.

Authors:  Grit Schröter; Daniel Mann; Carsten Kötting; Klaus Gerwert
Journal:  J Biol Chem       Date:  2015-05-15       Impact factor: 5.157

4.  Impairment of adenylyl cyclase 2 function and expression in hypoxanthine phosphoribosyltransferase-deficient rat B103 neuroblastoma cells as model for Lesch-Nyhan disease: BODIPY-forskolin as pharmacological tool.

Authors:  Liz Kinast; Juliane von der Ohe; Heike Burhenne; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-05-03       Impact factor: 3.000

5.  Refolding of G protein alpha subunits from inclusion bodies expressed in Escherichia coli.

Authors:  Emily McCusker; Anne Skaja Robinson
Journal:  Protein Expr Purif       Date:  2007-12-08       Impact factor: 1.650

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.